"Научный медицинский исследовательский центр онкологии имени Николая Николаевича Блохина – крупнейший Онкоцентр России и мира. Вот уже почти 70 лет Онкоцентр – это уникальный симбиоз науки и клинической практики, мультидисциплинарный подход к лечению онкологических больных, хирургическая школа, известная далеко за пределами России. Здесь изучаются и совершенствуются морфологические, иммунологические и генетические методы диагностики. Специалисты Блохина – авторы клинических рекомендаций по онкологии. Ежегодно в Онкоцентре противоопухолевое лечение проходят более 35 тысяч пациентов всех возрастов. Еще почти 6 000 граждан России получают помощь дистанционно – посредством телемедицинских консультаций."

During the past decade, Rossijskij onkologicheskij nauchnyj centr im. N.N. Blokhina RAMN conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rossijskij onkologicheskij nauchnyj centr im. N.N. Blokhina RAMN" #1 collaborator was "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rossijskij onkologicheskij nauchnyj centr im. N.N. Blokhina RAMN" are "Disease, Hodgkin" (2 trials), "Lymphoma, Large-Cell, Anaplastic" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Lymphoma, T-Cell, Cutaneous" (1 trials). Many other conditions were trialed in "Rossijskij onkologicheskij nauchnyj centr im. N.N. Blokhina RAMN" in a lesser frequency.

Most popular intervention types in "Rossijskij onkologicheskij nauchnyj centr im. N.N. Blokhina RAMN" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "brentuximab vedotin" (2 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rossijskij onkologicheskij nauchnyj centr im. N.N. Blokhina RAMN" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rossijskij onkologicheskij nauchnyj centr im. N.N. Blokhina RAMN". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rossijskij onkologicheskij nauchnyj centr im. N.N. Blokhina RAMN, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rossijskij onkologicheskij nauchnyj centr im. N.N. Blokhina RAMN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".